(Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
Sales | 79,180 | 73,670 | 63,130 | 44,530 | 34,920 |
Sales Growth | +7.48% | +16.70% | +41.77% | +27.52% | unch |
Net Income | -3,850 | -29,630 | -43,990 | 5,280 | 3,630 |
Net Income Growth | +87.01% | +32.64% | -933.14% | +45.45% | +116.24% |
Journey Medical Corp (DERM)
3.80 -0.04 (-1.04%) 13:56 ET [NASDAQ]
3.78 x 500 3.82 x 200
Realtime by (Cboe BZX)
3.78 x 500 3.82 x 200
Realtime - - (-) -
for Thu, Jan 16th, 2025
Journey Medical Corporation is a commercial-stage pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Journey Medical Corporation is based in Scottsdale, Arizona.
Fiscal Year End Date: 12/31